Results of three different trials showed pulmonary vein isolation ablation with Medtronic’s Arctic Front Advance cardiac cryoballoon is a safe and effective “first line” option for patients with atrial fibrillation, even if they have not already tried drug therapy.
The company hopes the results of these trials will lead the US Food and Drug Administration to expand the approved indication for Arctic Front Advance to include patients whose atrial...